Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02383927 |
|---|---|
| Brief Title: | Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations |
| First Submitted : | February 20, 2015 |
| First Submitted that Met QC Criteria : | March 3, 2015 |
| First Posted : | March 10, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | May 12, 2021 |
| Last Update Posted : | May 14, 2021 |